Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Philip Morris International Inc.PM · Entity 2818 | Chief Life Sciences Officer | January 04, 2021 | April 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Philip Morris International Inc.
Report date January 04, 2021 · Filed April 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,570 |
Ending reported balance
After 2021-01-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-01-04 · Grant · Acquired 9,785 · Balance 9,785 F1: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 3, 2022. These RSUs were erroneously filed on a Form 3 on January 11, 2021. F3: The average of the high and low price of Philip Morris International Inc. common stock on January 4, 2021. Row 2 · 2021-01-04 · Grant · Acquired 9,785 · Balance 19,570 F2: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 2, 2023. These RSUs were erroneously filed on a Form 3 on January 11, 2021. F3: The average of the high and low price of Philip Morris International Inc. common stock on January 4, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 3, 2022. These RSUs were erroneously filed on a Form 3 on January 11, 2021.
F2: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 2, 2023. These RSUs were erroneously filed on a Form 3 on January 11, 2021.
F3: The average of the high and low price of Philip Morris International Inc. common stock on January 4, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2021 Filed Feb 8, 2021 23:13 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 5,120 | $81.86 | $419,097.60 |
DisclosureSEC source: 0001182489-21-000022 · edgar.xml · nonDerivative · entry 1 Insuasty Jorge · CIK 0001839239 · Chief Life Sciences Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 F1 · shares: Restricted Share Units awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan. These Restricted Share Units will vest on February 21, 2024. F2 · price: The average of the high and low price of Philip Morris International Inc. common stock on February 4, 2021. F3 · balance_after: Restricted Share Units. Read SEC document |
| January 04, 2021 Filed Apr 1, 2021 20:24 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 9,785 | $81.36 | $796,058.68 |
DisclosureSEC source: 0001182489-21-000070 · edgar.xml · nonDerivative · entry 2 Insuasty Jorge · CIK 0001839239 · Chief Life Sciences Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,570 F2 · shares: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 2, 2023. These RSUs were erroneously filed on a Form 3 on January 11, 2021. F3 · price: The average of the high and low price of Philip Morris International Inc. common stock on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Apr 1, 2021 20:24 UTC | Philip Morris International Inc. PM · Entity 2818 | GrantCommon Stock | 9,785 | $81.36 | $796,058.68 |
DisclosureSEC source: 0001182489-21-000070 · edgar.xml · nonDerivative · entry 1 Insuasty Jorge · CIK 0001839239 · Chief Life Sciences Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,785 F1 · shares: Restricted Share Units ("RSUs") awarded under the Philip Morris International Inc. 2017 Performance Incentive Plan on January 4, 2021. These RSUs will vest at 100% on January 3, 2022. These RSUs were erroneously filed on a Form 3 on January 11, 2021. F3 · price: The average of the high and low price of Philip Morris International Inc. common stock on January 4, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.